1. Control of cell death and mitochondrial fission by ERK1/2 MAP kinase signalling. (18th June 2017) Authors: Cook, Simon J.; Stuart, Kate; Gilley, Rebecca; Sale, Matthew J. Journal: FEBS journal Issue: Volume 284:Number 24(2017) Page Start: 4177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Glycan Therapeutics: Resurrecting an Almost Pharma‐Forgotten Drug Class (Adv. Therap. 8/2018). Issue 8 (10th December 2018) Authors: Paderi, John; Prestwich, Glenn D.; Panitch, Alyssa; Boone, Tom; Stuart, Kate Journal: Advanced therapeutics Issue: Volume 1:Issue 8(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Glycan Therapeutics: Resurrecting an Almost Pharma‐Forgotten Drug Class. Issue 8 (24th August 2018) Authors: Paderi, John; Prestwich, Glenn D.; Panitch, Alyssa; Boone, Tom; Stuart, Kate Journal: Advanced therapeutics Issue: Volume 1:Issue 8(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Localized inhibition of platelets and platelet derived growth factor by a matrix targeted glycan mimetic significantly attenuates liver fibrosis. (February 2021) Authors: Kabra, Harsha; Walimbe, Tanaya; Stuart, Kate; Indey, Camille; Jalgaonkar, Swati; Ikwa, Elvis; Skurnac, Taylor; Chen, Julia; Woolley, Andrew; Snead, Nicholas M.; Bachtell, Nathan; Leeming, Diana J.; Karsdal, Morten; Prestwich, Glenn; Panitch, Alyssa; Paderi, John Journal: Biomaterials Issue: Volume 269(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗